findmyKOL
Clinical trialNCT07172204RecruitingPhase 2Interventional

Alternating Regimen of VA and Low-dose CHA in the Treatment of Unfit Newly Diagnosed AML

SponsorFirst Affiliated Hospital of Zhejiang UniversityEnrollment25Age ≥60Intensive Chemotherapy UnfitNewly Diagnosed Acute Myeloid Leukemia (AML)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Jie Dr. Sun, M.D, Ph.D

    Bone Marrow Transplantation Center of The First Affiliated Hospital, Zhejiang University School of Medicine

    Principal Investigator
  • Shanshan Prof. Pei, Ph.D

    Liangzhu Laboratory, Zhejiang University School of Medicine

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

China
  • Beijing Chao-Yang Hospital, Capital Medical University

    Beijing, Beijing Municipality, China

    Recruiting
  • Shenzhen University General Hospital

    Shenzhen, Guangdong, China

    Recruiting
  • the First Affiliated Hospital of Soochow University

    Suzhou, Jiangsu, China

    Recruiting
  • the Second Affiliated Hospital of Nanchang University

    Nanchang, Jiangxi, China

    Recruiting
  • Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine

    Hangzhou, Zhejiang, China

    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
16 Sept 2025
Primary completion
31 Jul 2027
Completion
31 Jul 2029
Last update posted
4 Feb 2026
Registered enrollment
25
Registry id
NCT07172204

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.